Interleukin-1: Basic science and clinical applications

Critical Reviews in Oncogenesis

Volumn 8, Issue 2-3, 1997, Pages 143-188

  Patarca, Roberto ^a   Fletcher, Mary Ann ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Receptor; Signal transduction

Indexed keywords

INTERLEUKIN 1;

CELLULAR IMMUNITY; CLINICAL IMMUNOLOGY; CLINICAL MEDICINE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOGENESIS; PHYSIOLOGY; REVIEW; SCIENCE; TUMOR IMMUNOLOGY;

EID: 0031448170     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v8.i2-3.20     Document Type: Review

References (474)

1. Akahoshi, T., J. J. Oppenheim, and K. Matsushima: Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s). J. Clin. Invest., 82:1219 (1988).
2. Alheim, K., T. L. McDowell, J. A. Symons, G. W. Duff, and T. Bartfai: An AP-1 site is involved in the NGF induction of IL-1 alpha in PC12 cells. Neurochem. Int., 29:487 (1996).
3. Andersen, L. S., J. Petersen, M. Svenson, and K. Bendtzen: IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon adherence of human serum and plasma constituents. Autoimmunity, 22:127 (1995).
4. Ansel, J. C., T. A. Luger, D. Lowry, P. Perry, D. R. Roop, and J. D. Mountz: The expression and modulation of IL-1 a in murine keratinocytes. J. Immunol., 140:2274 (1988).
5. Arend, W. P., D. F. Gordon, W. M. Wood, R. W. Janson, F. G. Joslin, and S. Jameel: IL-1β production in cultured human monocytes is regulated at multiple levels. J. Immunol., 143:118 (1989a).
6. Arend, W. P., F. G. Joslin, R. C. Thompson, and C. H. Hannum: An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J. Immunol., 143:1851 (1989b).
7. Arend, W. P.: Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest., 88:1445 (1991).
8. Asada, K., F. Ogushi, K. Tani, K. Maniwa, W. Ichikawa, T. Endo, L. Haung, Y. Nishioka, S. Sone, and T. Ogura: The role of cell-associated interleukin-1 in bleomycin- induced pulmonary fibrosis. Tokushima J. Exp. Med., 43:79 (1996).
9. Auron, P. E., A. C. Webb, L. J. Rosenwasser, S. F. Mucci, A. Rich, S. M. Wolff, and C. A. Dinarello: Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. U.S.A., 81:7907 (1984).
10. Austgulen, R., J. Hammerstrom, and J. Nissen-Meyer: In vitro cultured human monocytes release fibroblast proliferation factor(s) different from interleukin 1. J. Leukocyte Biol., 42:1 (1987).
11. 2 production in resting macrophages, Biochem. Biophys. Res. Commun., 136:94 (1986).
12. Bagby, G. C. Jr., C. A. Dinarello, P. Wallace, C. Wagner, S. Hefeneider, and E. McCall: Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J. Clin. Invest., 78:1316 (1986).
13. Bagby, G. C., Jr., C. A. Dinarello, R. C. Neerhout, D. Ridgway, and E. McCall: Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J. Clin. Invest., 82:1430 (1988).
14. Bagby, G. C., Jr.: Interleukin-1 and hematopoiesis. Blood Rev., 3:152 (1989).
15. Baldari, C. T. and J. L. Telford: The intracellular precursor of IL-1β is associated with microtubules in activated U937 cells. J. Immunol., 142:785 (1989).
16. Ballou, L. R., S. C. Barker, A. E. Postlethwaite, and A. H. Kang: Interleukin-1 stimulates phosphatidylinositol kinase activity in human fibroblasts. J. Clin. Invest., 87:299 (1991).
17. 2-macroglobulin synthesis in rat hepatocyte primary cultures. FEBS Lett., 190:271 (1985).
18. Baumann, H., C. Richards, and J. Gauldie: Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J. Immunol., 139:4122 (1987).
19. Beach, J. E., R. C. Smallridge, C. A. Kinzer, E. W. Bernton, J. W. Holaday, and H. G. Fein: Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci., 44:1 (1989).
20. Bender, S., H. D. Haubeck, E. Vandeleur, G. Dufhues, X. Schiel, J. Lauwerijns, H. Greiling, and P. C. Heinrich: Interleukin-1β induces synthesis and secretion of interleukin-6 in human chondrocytes. FEBS Lett., 263:321 (1990).
21. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J. H. Nielsen, C. A. Dinarello, and M. Svenson: Cytotoxicity of human interleukin-1 for pancreatic islets of Langerhans. Science, 232:1545 (1986).
22. Benjamin, D., S. Wormsley, and S. K. Dower: Heterogeneity in interleukin (IL)-1 receptors expression on human B cell lines. Differences in the molecular properties of IL-1α and IL-1β binding sites. J. Biol. Chem., 265 (1990).
23. Bennicelli, J. L., J. Elias, J. Kern, and D. Guerry, IV: Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res., 49:930 (1989).
24. Bensi, G., G. Raugei, E. Palla, V. Carinci, D. T. Buonamasa, and M. Melli: Human interleukin-1β gene.Gene, 52:95 (1987).
25. Beresini, M. H., M. J. Lempert, and L. B. Epstein: Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-α, inteferon-β, interleukin 1α, interleukin 1β, and tumor necrosis factor. J. Immunol., 140:485 (1988).
26. Berkowitz-Balshayi, C. and Y. Becker: Immunomodulation by OK-432 and calcitonin gene-related peptide (CGRP) of nitric oxide synthase (NOS) and IL-1 beta gene expression and of HSV-1 pathogenicity in mouse skin Langerhans cells. In Vivo, 9:447 (1995).
27. Bernton, E. W., J. E. Beach, J. W. Holaday, R. C. Smallridge, and H. G. Fein: Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science, 238:519 (1987).
28. Bertoglio, J. H.: B-cell-derived human interleukin-1. CRC Crit. Rev. Immunol., 8:299 (1988).
29. Besedovsky, H., A. del Rey, E. Sorkin, and C. A. Dinarello: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233:652 (1986).
30. Best, C. L., and J. A. Hill: Interleukin-1 alpha and -beta modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis. Human Reprod., 10:3206 (1995).
31. Bethea, J. R., G. Y. Gillespie, and E. N. Benveniste: Interleukin-1β induction of TNF-α gene expression - Involvement of protein kinase C. J. Cell. Physiol., 152:264 (1992).
32. Beuscher, H. U., C. Günther, and M. Röllinghoff: IL-1b is secreted by activated murine macrophages as biologically inactive precursor. J. Immunol., 144:2179 (1990).
33. Bienkowski, M. J., T. E. Eessalu, A. E. Berger, S. E. Truesdell, J. A. Shelly, A. L. Laborde, H. A. Zurcher-Neely, I. M. Reardon, R. L. Heinrikson, J. G. Chosay, and D. E. Tracey: Purification and characterization of interleukin 1 receptor level antagonist proteins from THP-1 cells. J. Biol. Chem., 265:14505 (1990).
34. Bingel, M., G. Lonnemann, K. M. Koch, C. A. Dinarello, and S. Shaldon: Enhancement of in vitro human interleukin-1 production by sodium acetate. Lancet, 1:14 (1987).
35. Bird, T. A. and J. Saklatvala: Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature, 324:263 (1986).
36. Bird, T. A., A. Davies, S. A. Baldwin, and J. Saklatvala: Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J. Biol. Chem., 265:13578 (1990).
37. Bird, T. A., A. Woodward, J. L. Jackson, S. K. Dower, and J. E. Sims: Phorbol ester induces phosphorylation of the 80 kilodalton murine interleukin 1 receptor at a single threonine residue. Biochem. Biophys. Res. Commun., 177:61 (1991).
38. Blum-Degen, D., T. Muller, W. Kuhn, M. Gerlach, H. Przuntek, and P. Riederer: Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett., 202:17 (1995).
39. Bocquet, J., M. Daireaux, M. Langris, V. Jouis, J.-P. Pujol, R. Beliard, and G. Loyau: Effect of a interleukin-1 factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes, Biochem. Biophys. Res. Commun., 134:539 (1986).
40. Bomsztyk, K., J. E. Sims, T. H. Stanto, J. Slack, C. J. McMahan, M. A. Valentine, and S. K. Dower: Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc. Natl. Acad. Sci. U.S.A., 86:8034 (1989).
41. Bomsztyk, K., J. W. Rooney, T. Iwasaki, N. A. Rachie, S. K. Dower, and C. J. Sibley: Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways; role of protein kinase C. Cell Regul., 2:329 (1991).
42. Bonin, P. D. and Singh, J. P., Modulation of interleukin-1 receptor expression and interleukin-1 response in fibroblasts by platelet-derived growth factor. J. Biol. Chem., 263:11052 (1988).
43. Bonin, P. D., W. J. Chiou, J. E. McGee, and J. P. Singh: Two signal transduction pathways mediate interleukin-1 receptor expression in Balb/c3T3 fibroblasts. J. Biol. Chem., 265:18643 (1990).
44. Bot, F. J., P. Schipper, L. Broeders, R. Delwel, K. Kaushansky, and B. Löwenberg: Interleukin-1α also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells. Blood, 76:307 (1990).
45. Bradbury, D., G. Bowen, R. Kozlowski, I. Reilly, and N. Russell: Endogenous interleukin-1 regulat the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF. Leukemia, 4:44 (1990).
46. Brandwein, S. R.: Regulation of interleukin 1 production by mouse peritoneal macrophages: effects of arachidonic acid metabolites, cyclic nucleotides, and interferons, J. Biol. Chem., 261:8624 (1986).
47. Braun, M., Pietsch, P., S. B. Felix, and G. Baumann: Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines. J. Mol. Cell. Cardiol., 27:2571 (1995).
48. Breder, C. D., C. A. Dinarello, and C. B. Saper: Interleukin-1 immunoreactive innervation of the human hypothalamus. Science, 240:321 (1988).
49. Bristol, L. A., M. R. Smith, N. K. Bhat, and S. K. Durum: IL-1 induces ornithine decarboxylase in normal lymphocytes-T. J. Immunol., 146:1509 (1991).
50. Bron, C. and H. R. MacDonald: Identification of the plasma membrane receptor for interleukin-1 on mouse thymoma cells. FEBS Lett., 219:365 (1987).
51. Brown, D., R. Sadeghi, J. Steel, M. Moore, and G. Gammon: Detection of interleukin-1 signal transduction inhibitors: action of protein kinase inhibitors. Int. J. Immunopharmacol., 17: 887 (1995).
52. Brown, K. M., A. V. Muchmore, and D. L. Rosenstreich: Uromodulin, an immmunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin-1. Proc. Natl. Acad. Sci. U.S.A., 83:9119 (1986).
53. Brown, S. L., L. R. Smith, and J. E. Blalock: Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J. Immunol., 139:3181 (1987).
54. Burch, R. M., M. F. White, and J. R. Connor: Interleukin 1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interactions between two second messenger systems. J. Cell. Physiol., 139:29 (1989).
55. Busson, P., K. Braham, G. Ganem, F. Thomas, D. Grausz, M. Lipinski, H. Wakasugi, and T. Tursz: Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin-1α. Proc. Natl. Acad. Sci. U.S.A., 84:6262 (1987).
56. Butler, D. M., R. M. Maini, M. Feldmann, and F. M. Brennan: Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur. Cytokine Netw., 6:225 (1995).
57. Butner, L., Y. Huang, E. Tse, and I. H. Hall: Anti-inflammatory activity of 2,3-dihydrophthalazine-1,4-diones in CFI mice. Int. J. Tissue React., 18:47 (1996).
58. + exchange is not required for differentiation in pre-B lymphocytic cell line, 70Z/3. J. Biol. Chem., 262:3680 (1987).
59. Calkins, J. H., M. M. Sigel, H. R. Nankin, and T. Lin: Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture. Endocrinology, 123:1605 (1988).
60. Calkins, J. H., H. Guo, M. M. Sigel, and T. Lin: Tumor necrosis factor-α enhances inhibitory effects of interleukin-1β on Leydig cell steroidogenesis. Biochem. Biophys. Res. Commun., 166:1313 (1990).
61. Cameron, P., G. Limjuco, J. Rodkey, C. Bennett, and J. A. Schmidt: Amino acid sequence analysis of human interleukin 1 (IL-1): evidence for biochemically distinct forms of IL-1. J. Exp. Med., 162:790 (1985).
62. Cameron, P. M., G. A. Limjuco, J. Chin, L. Silberstein, and J. A. Schmidt: Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. J. Exp. Med., 164:237 (1986).
63. Canalis, E.: Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology, 118:74 (1986).
64. Cannon, J. G., J. B. Tatro, S. Reichlin, and C. A. Dinarello: α Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J. Immunol., 137:2232 (1986).
65. Carley, W. W., A. Szczepanski, and M. E. Gerritsen: Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth. Microcirculation, 3:359 (1996).
66. Carter, D. B., M. R. Delbel, Jr., C. J. Dunn, C.-S. C. Tomich, A. L. Laborde, J. L. Slightom, A. E. Berger, M. J. Bienkowski, F. F. Sun, R. N. McEwan, P. K. W. Harris, A. W. Yem, G. A. Waszak, J. G. Chosay, L. C. Sieu, M. M. Hardee, H. A. Zurcher-Neely, I. M. Reardon, R. L. Heinrikson, S. E. Truesdell, J. A. Shelly, T. E. Eessalu, B. M. Taylor, and D. E. Tracey: Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature, 344:633 (1990).
67. Cerretti, D. P., C. J. Kozlowky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black: Molecular cloning of the interleukin-1β converting enzyme. Science, 256:97 (1992).
68. Chai, Z., K. Alheim, J. Lundkvist, S. Gatti, and T. Bartfai: Subchronic glucocorticoid pretreatment reversily attenuates IL-1beta induced fever in rats; IL-6 mRNA is elevated while IL-1 alpha and IL-1 beta mRNAs are suppressed, in the CNS. Cytokine, 8:227 (1996).
69. Chandrasekhar, S. and A. K. Harvey: Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: a possible mechanism for modulation of interleukin-1 activity. J. Cell. Physiol., 138:236 (1989).
70. Chao, C. C., S. Hu, L. Ehrlich, and P. K. Peterson: Interleukin-1 and tumor necrosis factor-alpha syndergistically mediate neurotoxicity: involvement if nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun., 9:355 (1995).
71. Chin, J., P. M. Cameron, E. Rupp, and J. A. Schmidt: Identifiction of a high-affinity receptor for native human interleukin 1β and interleukin 1α on normal human lung fibroblasts. J. Exp. Med., 165:70 (1987).
72. Chiou, W. J., P. D. Bonin, P. K. W. Harris, D. B. Carter, and J. P. Singh: Platelet-derived growth factor induces interleukin-1 receptor gene expression in Balb/c 3T3 fibroblasts. J. Biol. Chem., 264:21442 (1989).
73. 2 production in fibroblasts. Potential role of growth factors in modulation of tissue response to IL-1. J. Immunol., 145:2155 (1990).
74. Chiplunkar, S., J. Langhorne, and S. H. E. Kauffman: Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. J. Immunol., 137:3753 (1986).
75. Chiu, W. T., T. Y. Kao, and M. T. Lin: Interleukin-1 receptor antagonist increases survival in rat heatstroke by reducing hypothalamic serotonin release. Neurosci. Lett., 202:33 (1995).
76. Chizzonite, R., T. Truitt, P. L. Kilian, A. S. Stern, P. Nunes, K. P. Parker, K. L. Kaffka, A. O. Chua, D. K. Lugg, and U. Gubler: Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl. Acad. Sci. U.S.A., 86:8029 (1989).
77. Cianciolo, G. J., T. D. Copeland, S. Oroszlan, and R. Snyderman: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins, Science, 230:453 (1985).
78. + antiport in a murine T cell. J. Immunol., 143:4000 (1989).
79. Clark, B. D., K. L. Collins, M. S. Gandy, A. C. Webb, and P. E. Auron: Genomic sequence for human prointerleukin 1β: possible evolution from a reverse transcribed prointerleukin 1α gene. Nucleic Acids Res., 14:7897 (1986).
80. Collart, M. A., D. Belin, J.-D. Vassalli, S. de Kossodo, and P. Vasalli: γ Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressers. J. Exp. Med., 164:2113 (1986).
81. Comens, P. G., B. A. Wolf, E. R. Unanue, P. E. Lacy, and M. L. McDaniel: Interleukin-1 is potent modulator of insulin secretion from isolated rt islets of Langerhans. Diabetes, 36:963 (1987).
82. Conlon, P. J., K. H. Grabstein, A. Alpert, K. S. Prickett, T. P. Hopp, and S. Gillis: Localization of human mono-nuclear cell interleukin 1. J. Immunol., 139:98 (1987).
83. Corbett, J. A., G. Kwon, J. Turk, and M. L. McDaniel: IL-1β induces the coexpression of both nitric oxide and cyclooxygenase by islets of Langerhans - Activation of cyclooxygenase by nitric oxide, Biochemistry, 32:13767 (1993).
84. Cozzolino, F., A. Rubartelli, D. Aldinucci, R. Sitia, M. Torcia, A. Shaw, and R. Di Guglielmo: Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. U.S.A., 86:2369 (1989).
85. Curtis, B. M., M. B. Widmer, P. DeRoos, E. E. Quarnstrom: IL-1 and its receptor are translocated to the nucleus. J. Immunol., 144:1295 (1990).
86. Darlington, G. J., D. R. Wilson, and L. B. Lachman: Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J. Cell Biol., 103:787 (1986).
87. Davidson, J. A., U. Tiemann, J. G. Betts, and P. J. Hansen: DNA synthesis and prostaglandin secretion by bovine endometrial cells as regulated by interleukin-1. Reprod. Fertil. Dev., 7:1037 (1995).
88. Dawson, J., U. Hurtenbach, and A. MacKenzie: Cyclosporin A inhibits the in vivo production of interleukin-1beta and tumor necrosis factor alpha, but not interleukin-6, by a T-cell-independent mechanism. Cytokine, 8:882 (1996).
89. Daynes, R. A., B. A. Robertson, B.-H. Cho, D. K. Burnham, and R. Newton: α-Melanocyte stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J. Immunol., 139:103 (1987).
90. De Benedetti, F., P. Pignatti, M. Massa, P. Sarturana, A. Ravelli, and A. Martini: Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. Clin. Exp. Rheumatol., 13:779 (1995).
91. DeChiara, T. M., D. Young, R. Semionow, A. S. Stern, C. Batula-Bernardo, C. Fiedler-Nagy, K. L. Kaffka, P. L. Kilian, S. Yamazaki, S. B. Mizel, and P. T. Lomedico: Structure-function analysis of murine interleukin 1: biologically active polypeptides are at least 127 amino acids long and are derived from the carboxyl terminus of a 270-amino acid precursor. Proc. Natl. Acad. Sci. U.S.A., 83:8303 (1986).
92. Dedhar, S.: Regulation of expression of the cell adhesion recpetors, integrins, by recombinant human interleukin-1β in human osteosarcoma cells: inhibition of cell proliferation and stimulation of alkaline phosphatase activity. J. Cell. Physiol., 138:291 (1989).
93. Delwel, R., C. van Buitenen, M. Salem, F. Bot, S. Gillis, K. Kaushansky, B. Altrock, and B. Löwenberg: Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release. Blood, 74:586 (1989).
94. DeMarco, D., S. L. Kunkel, R. M. Stricter, M. Basha, and R. B. Zurier: Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem. Biophys. Res. Commun., 174:411 (1991).
95. Demczuk, S., C. Baumberger, B. Mach, and J.-M. Dayer: Expression of human IL-1 α and β messenger RNAs and IL 1 activity in human peripheral blood mononuclear cells. J. Mol. Cell. Immunol., 3:255 (1987).
96. Dewhirst, F. E., P. Stashenko, J. E. Mole, and T. Tsuramachi: Purification and partial sequence of human osteoclastacting factor: identity with interleukin-1β. J. Immunol., 135:2262 (1985).
97. Didier, M., C. Aussel, C. Pelassy, and M. Fehlmann: IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis. J. Immunol., 141:3078 (1988).
98. Dinarello, C. A.: Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med., 311:1413 (1984).
99. Dinarello, C. A.: The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol. Lett., 16:227 (1987).
100. Dinarello, C. A.: Interleukins, tumor necrosis factors (cachetin), and interferons as endogenous pyrogens and mediators of fever. Lymphokines, 14:1 (1987).
101. Dinarello, C. A. and N. Savage: Interleukin-1 and its receptor. Crit. Rev. Immunol., 9:1 (1989).
102. Donnelly, R. P., M. J. Fenton, J. D. Kaufman, and T. L. Gerrard: IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J. Immunol., 146:3431 (1991).
103. Dower, S. K., S. R. Kronheim, C. J. March, P. J. Conlon, T. P. Hopp, S. Gillis, and D. L. Urdal: Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J. Exp. Med., 162:501 (1985).
104. Dower, S. K., S. M. Call, S. Gillis, and D. L. Urdal: Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc. Natl. Acad. Sci. U.S.A., 83:1060 (1986).
105. Doyle, M. V., L. Brindley, E. Kawasaki, and J. Larrick: High level human interleukin 1 production by a hepatoma cell line. Biochem. Biophys. Res. Commun., 130:768 (1985).
106. Ehrlich, W., H. Huser, and H. Kroger: Inhibition of the induction of collagenase by interleukin-1 beta in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenza. Rheumatol. Int., 15:171 (1995a).
107. Ehrlich, W., H. Huser, and H. Kroger: Induction and activation of procollagenase in rabbit synovial fibroblasts after treatment with active oxygen released by xanthine/xanthine oxidase. Rheumatol. Int., 15:131 (1995b).
108. Eisenberg, S. P., R. J. Evans, W. P. Arend, E. Verderber, M. T. Brewer, C. H. Hannum, and R. C. Thompson: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature, 343:341 (1990).
109. Eisenberg, S. P., M. T. Brewer, E. Verderber, P. Heimdal, B. J. Brandhuber, and R. C. Thompson: Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc. Natl. Acad. Sci. U.S.A., 88:5232 (1991).
110. Eizirik, D. L., A. Björklund, and N. Welsh: Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett., 317:62 (1993).
111. Elsayed, Y. A., K. Nakagawa, K. Ichikawa, S. Ohkawara, and K. Sueishi: Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipopolysaccharide. Pathobiology, 63:328 (1995).
112. Emeis, J. J., R. Hoekzema, and A. F. de Vos: Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood, 85:115 (1995).
113. Endo, Y., K. Matsushima, and J. J. Oppenheim: Mechanism of in vitro antitumor effects of interleukin 1 (IL 1). Immunobiology, 172:316 (1986).
114. Endo, Y., K. Matsushima, K. Onozaki, and J. J. Oppenheim: Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. J. Immunol., 141:2342 (1989).
115. Estrov, Z., R. Kurzrock, and M. Talpaz: Interleukin-1 and its inhibitors: implications for disease biology and therapy. Cancer Treat. Res., 80:51 (1995).
116. Etienne, P., N. Pares-Herbute, and L. Monnier: Regulation of growth of cultured smooth muscle cells from diabetic rats by interleukin-1 beta: role of nitric oxide. Eur. J. Pharmacol., 11:79 (1996).
117. Evans, R. and T. M. Duffy: Activation of the IL-1 pathway during amplification of immune responses in tumor-bearing mice. Cell. Immunol., 105:86 (1987).
118. Evans, R., T. M. Duffy, S. S. Blake, and H.-S. Lin: Regulation of systemic macrophage IL-1 gene transcription: the involvement of tumor-derived macrophage growth factor, CSF-1. J. Leukocyte Biol., 46:428 (1989).
119. Fagarasan, M. O., J. Axelrod, and K. J. Catt: Interleukin-1 potentiates agonist-induced secretion of β-endorphin in anterior pituitary cells. Biochem. Biophys. Res. Commun., 173:988 (1990a).
120. Fagarasan, M. O., J. F. Bishop, M. S. Rinaudo, and J. Axelrod: Interleukin 1 induces early protein phosphorylation and requires only a short exposure for late induced secretion of β-endorphin in a mouse pituitary cell line. Proc. Natl. Acad. Sci. U.S.A., 87:2555 (1990b).
121. Fagarasan, M. O., F. Aiello, K. Muegge, S. Durum, and J. Axelrod: Interleukin 1 induces β-endorphin secretion via Fos and Jun in AtT-20 pituitary cells. Proc. Natl. Acad. Sci. U.S.A., 87:7871 (1990c).
122. Fey, G. H. and G. M. Fuller: Regulation of acute phase gene expression by inflammatory mediators. Mol. Biol. Med., 4:323 (1987).
123. Fibbe, W. E., J. van Damme, A. Billiau, H. M. Goselink, P. J. Voogt, G. van Eeden, P. Ralph, B. W. Altrock, and J. H. Falkenburg: Interleukin-1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood, 71:430 (1988).
124. Fibbe, W. E., M. R. Schaafsma, J. H. F. Falkenburg, and R. Willemze: The biological activities of interleukin-1. Blut, 59:147 (1989a).
125. Fibbe, W. E., M. R. Daha, P. S. Hiemstra, N. Duinkerken, E. Lurvink, P. Ralph, B. W. Altrock, K. Kaushansky, R. Willemze, and J. H. F. Falkenburg: Interleukin 1 and poly(rI)poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp. Hematol., 17:229 (1989b).
126. Flad, H.-D., H. Kirchner, and K. Resch: Interleukin 1 and related cytokines. Lymphokine Res., 8:227 (1989).
127. Flad, H.-D., J. Gercken, L. Hubner, C. Schluter, J. Pryjma, and M. Ernst: Cytokines in mycobacterial infections: in vivo and ex vivo studies. Arch. Immunol. Ther. Exp., 43:153 (1995).
128. Fotedar, R. and E. Diener: The role of recombinant IL-2 and IL-1 in murine B cell differentiation. Lymphokine Res., 7:393 (1988).
129. Franke-Ullmann, G., C. Pfortner, P. Walter, C. Steinmuller, M. L. Lohmann-Matthes, L. Kobzik, and J. Freihorst: Alteration of pulmonary macrophage function by respiratory synsytial virus infection in vitro. J. Immunol., 154:268 (1995).
130. Freedman, A. S., G. Freeman, J. Whitman, J. Segil, J. Daley, and L. M. Nadler: Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. J. Immunol., 141:3398 (1988).
131. Fryling, C., M. Dombalagian, W. Burgess, N. Hollander, A. B. Schereiber, and J. Haimovich: Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1. Cancer Res., 49:3333 (1989).
132. Fuhlbrigge, R. C., K. A. Hogquist, E. R. Unanue, and D. D. Chaplin: Molecular biology and genetics of interleukin-1. Year Immunol., 5:21 (1989).
133. Fujioka, N., R. Akazawa, K. Sakamoto, K. Ohashi, and M. Kurimoto: Potential application of human interferon-alpha in microbial infections of the oral cavity. J. Interferon Cytokine Res., 15: 1047 (1995).
134. Fukuoka, M., K. Yasuda, S. Taii, K. Takakura, and T. Mori: Interleukin-1 stimulates growth and inhibits progesterone secretion in cultures of porcine granulosa cells. Endocrinology, 124:884 (1989).
135. Furutani, Y., M. Notake, T. Fukui, M. Ohue, H. Nomura, M. Yamada, and S. Nakamura: Complete nucleotide sequence of the gene for human interleukin 1α. Nucleic Acids Res., 14:3167 (1986).
136. Gaffney, E. V. and S.-C. Tsai: Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1. Cancer Res., 46:3834 (1986).
137. Gaffney, E. V., G. Koch, S.-C. Tsai, T. Louks, and S. E. Lingenfelter: Correlation between human cell growth response to interleukin 1 and receptor binding. Cancer Res., 48:5455 (1988).
138. Gallagher, G., J. F. Christie, and W. H. Stimson: Interleukin-1α, but not interleukin-1β, can induce S-phase entry in human B-CLL B-cells. IRCS Med. Sci. Biochem., 14:770 (1986).
139. Gallicchio, V. S., T. D. Watts, and R. DellaPuca: Synergistic action of recombinant-derived murine interleukin-1 on the augmentation of colony-stimulating activity on murine granulocyte-macrophage hematopoietic stem cells in vitro. Exp. Cell Biol., 55:83 (1987).
140. Gallis, B., K. S. Prickett, J. Jackson, J. Slack, K. Schooley, J. E. Sims, and S. K. Dower: IL-1 induces rapid phosphorylation of the IL-1 receptor. J. Immunol., 143:3235 (1989).
141. Garcia-Welsh, A., J. S. Schneiderman, and D. L. Baly: Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1β and IL-1α. FEBS Lett., 269:421 (1990).
142. Gauldie, J., D. N. Sauder, K. P. W. J. McAdam, and C. A. Dinarello: Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology, 60:203 (1987).
143. Gay, C. G. and J. A. Winkles: Interleukin-1 regulates heparin-binding growth factor-2 gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 88:296 (1991).
144. Gehrke, L., S. A. Jobling, L. S. K., Paik, B. McDonald, L. J. Rosenwasser, and P. E. Auron: A point mutation uncouples human interleukin-1β biological activity and receptor binding. J. Biol. Chem., 265:5922 (1990).
145. Georgilis, K., C. Schaefer, C. A. Dinarello, and M. S. Klempner: Human recombinant interleukin 1β has no effect on intracellular calcium or on functional responses of human neutrophils. J. Immunol., 138:3403 (1987).
146. Gerard, N., V. Syed, W. Bardin, N. Genetet, and B. Jegou: Sertoli cells are the site of interleukin-1α synthesis in rat testis. Mol. Cell. Endocrinol. 82:R13 (1991).
147. Gerrard, T. L., J. P. Siegel, D. R. Dyer, and K. C. Zoon: Differential effects of interferon-α and interferon-γ on interleukin secretion by monocytes. J. Immunol. 138:- 2535 (1987).
148. Giri, J. G., R. C. Newton, and R. Horak: Identification of soluble interleukin-1 protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. J. Biol. Chem., 265:17416 (1990).
149. Giulian, D., T. J. Baker, L.-C.N. Shih, and L. B. Lachman: Interleukin-1 on the central nervous system is produced by ameboid microglia. J. Exp. Med., 164:594 (1986).
150. Godfrey, R. W., W. J. Johnson, and S. T. Hoffstein: Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem. Biophys. Res. Commun., 142:235 (1987).
151. Gong, J-H., H. Renz, M. Nain, and D. Gemsa: Interleukin 1 as a tumor cytostatic mediator released from tumor ascites-treated macrophages. Immunobiology, 177:339 (1988).
152. Goto, M., M. Sasano, H. Yamanaka, N. Miyasaka, N. Kamatani, K. Inoue, K. Nishioka, and T. Miyamoto: Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J. Clin. Invest., 80:786 (1987).
153. Gottlieb, R. A., W. J. Lennarz, R. D. Knowles, G. J. Cianciolo, C. A. Dinarello, L. B. Lachman, and E. S. Kleinerman: Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction. J. Immunol., 142:4321 (1989).
154. Gottschall, P. E., A. Uehara, S. T. Hoffmann, and A. Arimura: Interleukin-1 inhibits follicle stimulating hormone-induced differentiation in rat granulosa cells in vitro. Biochem. Biophys. Res. Commun., 149:502 (1987).
155. Gottschall, P. E., G. Katsuura, and A. Arimura: Interleukin-1β is more potent than interleukin-1α in suppressing follicle-stimulating hormone-induced differentiation of ovarian granulosa cells. Biochem. Biophys. Res. Commun., 163:764 (1989).
156. Goujon, E., P. Parnet, S. Laye, C. Combe, K. W. Kelley, and R. Dantzer: Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleeen, pituitary, and brain of mice. Brain Behav. Immun., 9:292 (1995).
157. Gray, P. W., D. Glaister, E. Chen, D. V. Goeddel, and D. Pennica: Two interleukin-1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1β. J. Immunol., 137:3644 (1986).
158. Grenfell, S., N. Smithers, K. Miller, and R. Solari: Receptor-mediated endocytosis and nuclear transport of human interleukin 1α. Biochem. J., 264:813 (1989).
159. Griffin, J. D., A. Rambaldi, E. Vellenga, D. C. Young, D. Ostapovicz, and S. A. Cannistra: Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood, 70:1218 (1987).
160. Gupta, S., B. Vayuvegula, M. Ruhling, and M. Thornton: Interleukin 1 and interleukin 12 production in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. J. Clin. Lab. Immunol., 22:113 (1987).
161. Gwosdow, A. R., J. A. Spencer, N. A. O'Connell, and A. B. Abou-Samra: Interleukin-1 activates protein kinase A and stimulates adrenocorticotropic hormone release from AtT-20 cells. Endocrinology, 132:710 (1993).
162. Hagiwara, H., H.-J. S. Huang, N. Arai, L.A. Herzenberg, K.-I. Arai, and A. Zlotnik: Interleukin 1 modulates messenger RNA levels of lymphokines and of other molecules associated with T cell activation in the T cell lymphoma LBRM33-1A5. J. Immunol., 138:2514 (1987).
163. Hamburger, A. W., K. A. Lurie, and M. E. Condon: Stimulation of anchorage-independent growth of human tumor cells by interleukin 1. Cancer Res., 47:5612 (1987).
164. Hamby, B. A., E. M. Huggins, Jr., L. B. Lachman, C. A. Dinarello, and M. M. Sigel: Fish lymphocytes respond to human IL-1. Lymphokine Res., 5:157 (1986).
165. Hammonds, P., M. Beggs, G. Beresford, J. Espinal, J. Clarke, and R. J. Mertz: Insulin-secreting β-cells possess specific receptors for interleukin-1β. FEBS Lett., 261:97 (1990).
166. Hanazawa, S., Y. Ohmori, S. Amano, T. Miyoshi, M. Kumegawa, and S. Kitano: Spontaneous production of interleukin-1-like cytokine from a mouse osteoblastic cell line (MC3T3-E1). Biochem. Biophys. Res. Commun., 131:774 (1985).
167. Hannum, C. H., C. J. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature, 343:336 (1990).
168. Hao, W. and J. P. Palmer: The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured islets. Autoimmunity, 22:209 (1995a).
169. Hao, W. and J. P. Palmer: Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells. J. Interferon Cytokine Res., 15:1075 (1995b).
170. Haralabidis, S., E. Karagouni, S. Frydas, and E. Dotsika: Immunoglobulin and cytokine profile in murine secondary hydatidosis. Parasite Immunol., 17:625 (1995).
171. Harvey, A. K., P. S. Hrubey, and S. Chandrasekhar: Transforming growth factor-β inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptor on chondrocytes. Exp. Cell Res., 195:376 (1991).
172. Hauser, C., J.-H. Saurat, A. Schmitt, F. Jaunin, and J.-M. Dayer: Interleukin-1 as present in normal human epidermis. J. Immunol., 136:3317 (1986).
173. Hauser, C., J.-M. Dayer, F. Jaunin, B. de Rochemonteix, and J.-H. Saurat: Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431. Cell. Immunol., 100:89 (1986).
174. Hayes, R., S. A. Chalmers, D. J. Nikolic-Paterson, R. C. Atkins, and M. P. Hedger: Secretion of bioactive interleukin 1 by rat testicular macrophages in vitro. J. Androl., 17:41 (1996).
175. Hazuda, D., R. L. Webb, P. Simon, and P. Young: Purification and characterization of human recombinant precursor interleukin 1β. J. Biol., Chem., 264:1689 (1989).
176. Heguy, A., C. Baldari, K. Bush, R. Nagele, R. C. Newton, R. J. Robb, R. Horuk, J. L. Telford, and M. Melli: Internalization and nuclear localization of interleukin 1 are not sufficient for function. Cell Growth Differ., 2:311 (1991).
177. Heino, J. and T. Heinonen: Interleukin-1β prevents the stimulatory effect of transforming growth factor-β on collagen gene expression in human skin fibroblasts. Biochem. J., 271:827 (1990).
178. Herman, J. and A. R. Rabson: Tumor cells stimulate interleukin 1 (IL-1) production from enriched large granular lymphocytes. Clin. Immunol. Immunopathol., 38:282 (1986).
179. Hill, M. R., R. D. Stith, and R. E. McCallum: Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J. Immunol., 137:858 (1986).
180. Hiro, D., A. Ito, K. Matsuta, and Y. Mori: Hyaluronic acid is an endogenous inducer of interleukin-1 production by human monocytes and rabbit macrophages. Biochem. Biophys. Res. Commun., 140:715 (1986).
181. Hoang, T., A. Haman, O. Goncalves, F. Letendre, M. Mathieu, G. G. Wong, and S. C. Clark: Interleukin-1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hematopoietic precursors. J. Exp. Med., 168:463 (1988).
182. Hoffman, M. K.: The effects of tumor necrosis factor on the production of interleukin-1 by macrophages. Lymphokine Res., 5:255 (1986).
183. Hoffmann, O., K. Klaushofer, H. Gleispach, H. J. Leis, T. Luger, K. Koller, and M. Peterlik: Gamma interferon inhibits basal and interleukin 1-induced prostaglandin production and bone marrow resorption in neonatal mouse calvaria. Biochem. Biophys. Res. Commun., 143:38 (1987).
184. Hofmeister, R., D. N. Mannel, and W. Falk: Evidence for an intracellular activation loop in the Il-1 system, J. Inflamm., 47:151 (1995-1996).
185. Holden, R. J. and P. A. Mooney: Interleukin-1 beta: a common cause of Alzheimer's disease and diabetes mellitus. Med. Hypotheses, 45:559 (1995).
186. Hopp, T. P., S. K. Dower, and C. J. March: The molecular forms of interleukin-1. Immunol. Res., 5:271 (1986).
187. Horuk, R., J. J. Huang, M. Covington, and R. C. Newton: A biochemical and kinetic analysis of the interleukin-1 receptor. J. Biol. Chem., 262:16275 (1987).
188. Houssiau, F. A., P. G. Coulie, and J. Van Snick: Distinct roles of IL-1 and IL-6 in human T-cell activation. J. Immunol., 143:2520 (1989).
189. Hsu, S-M. and X. Zhao: Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from the histiocytic malignancies. Am. J. Pathol., 125:221 (1986).
190. Huang, J. J., R. C. Newton, R. Horuk, J. B. Matthew, M. Covington, K. Pezzella, and Y. Lin: Muteins of human interleukin-1 that show enhanced bioactities. FEBS Lett., 223:294 (1987).
191. Huang, J. J., R. C. Newton, S. J. Rutledge, R. Horuk, J. B. Matthew, M. Covington, and Y. Lin: Characterization of murine IL-1β: isolation, expression, and purification. J. Immunol., 140:3838 (1988).
192. Hughes, J. H., M. A. Watson, R. A. Easom, J. Turk, and M. L. McDaniel: Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified β cells. FEBS Lett., 266:33 (1990).
193. Hughes, T. K., E. Fulep, T. Juelich, E. M. Smith, and G. J. Stanton: Modulation of immune responses by anabolic androgenic steroids. Int. J. Immunopharmacol., 17:857 (1995).
194. Hulkower, K. I., H. I. Georgescu, and C. H. Evans: Evidence that responses of articular chondrocytes to interleukin-1 and basic fibroblast growth factor are not mediated by protein kinase C. Biochem. J., 276:157 (1991).
195. Izumi, T., S. Tajima, R. Harada, and T. Nishikawa: Reticular erythematous mucinosis syndrome: glycosaminoglycan synthesis by fibroblasts and abnormal response to interleukin-1 beta. Dermatology, 192:41 (1996).
196. Jobling, S. A., P. E. Auron, G. Gurka, A. C. Webb, B. McDonald, L. J. Rosenwasser, and L. Gehrke: L., Biological activity and receptor binding of human prointerleukin-1β and subpeptides. J. Biol. Chem., 263:16372 (1988).
197. Johnson, C. S., D. J. Keckler, M. I. Topper, P. G. Braunschweiger, and P. Furmanski: In vivo hematopoietic effects of recombinant interleukin-1α in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of eythroid suppression with erythropoietin. Blood, 73:678 (1989).
198. Kähäri, V.-M., J. Heino, and E. Vuorio: Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim. Biophys. Acta, 929:142 (1987).
199. Kalra, P. S., A. Sahu, and S. P. Kalra: Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. Endocrinology, 126:2145 (1990).
200. Kasahara, T., H. Yagisawa, K. Yamashita, Y. Yamaguchi, and Y. Akiyama: IL-1 induces proliferation and IL6 mRNA expression in a human astrocytoma cell line: positive and negative modulation by cholera toxin and cAMP, Biochem. Biophys. Res. Commun., 167:1242 (1990).
201. Katakami, Y., Y. Nakao, T. Matsui, T. Koizumi, K. Kaibuchi, Y. Takai, and T. Fujita: Possible involvement of protein kinase C in interleukin-1 production by mouse peritoneal macrophages. Biochem. Biophys. Res. Commun., 135:355 (1986).
202. Kauma, S. W.: Interleukin-1β stimulates colony-stimulating factor 1 production in human term placenta. J. Clin. Endocrinol. Metab., 76:701 (1993).
203. Kawabe, Y., K. Eguchi, C. Shimomura, M. Mine, T. Otsubo, Y. Ueki, H. Tezuka, H. Nakao, A. Kawakami, K. Migita, S. Yamashita, M. Matsunaga, N. Ishikawa, K. Ito, and S. Nagataki: Interleukin-1 production and action in thyroid tissue. J. Clin. Endocrinol. Metab., 68:1174 (1989).
204. Kawakami, M., S. Ishibashi, H. Ogawa, T. Murase, F. Takaku, and S. Shibata: Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem. Biophys. Res. Commun., 141:482 (1986).
205. Kelly, R. W., G. G. Carr, C. L. Elliott, M. Tulppala, and H. O. Critchley: Prostaglandin and cytokine release by trophoblastic villi. Hum. Reprod., 10:3289 (1995).
206. 2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. Biochem. Biophys. Res. Commun., 165:1079 (1989).
207. Kessler, D. J., M. P. Duyao, D. B. Spicer, and G. E. Sonenshein: NF-kappa B-like factors mediate interleukin-1 induction of c-myc gene transcription in fibroblasts. J. Exp. Med., 176:787 (1992).
208. Kester, M., M. S. Simonson, P. Mené, and J. R. Sedor: Interleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J. Clin. Invest., 83:718 (1989).
209. Khan, S. A., S. J. Khan, and J. H. Dorrington: Interleukin-1 stimulates deoxyribonucleic acid synthesis in immature rat Leydig cells in vitro. Endocrinology, 131:1853 (1992).
210. Kikumoto, Y., Y.-M. Hong, T. Nishida, S. Nakai, Y. Masui, and Y. Hirai: Purification and characterization of recombinant human interleukin-1β produced in Escherichia coli. Biochem. Biophys. Res. Commun., 147:315 (1987).
211. Kimball, E. S., S. F. Pickeral, J. J. Oppenheim, and J. L. Rossio: Interleukin 1 activity in normal human urine. J. Immunol., 133:256 (1984).
212. Kimura, H., S. Yamashita, H. Namba, T. Tominaga, M. Tsuruta, N. Yokoyama, M. Izumi, and S. Nagataki: Interleukin-1 inhibits human thyroid carcinoma cell growth. J. Clin. Endocrinol. Metab., 75:596 (1992).
213. Kleinerman, E. S., L. B. Lachman, R. D. Knowles, R. Snyderman, and G. J. Cianciolo: A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J. Immunol., 139:2329 (1987).
214. Knudsen, P. J., C. A. Dinarello, and T. B. Strom: Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. J. Immunol., 136:3311 (1986a).
215. Knudsen, P. J., C. A. Dinarello, and T. B. Strom: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol., 137:3189 (1986b).
216. Kobayashi, Y., E. Appella, M. Yamada, T. D. Copeland, J. J. Oppenheim, and K. Matsushima: Phosphorylation of intracellular precursors of human IL-1. J. Immunol., 140:2279 (1988).
217. Köck, A., M. Danner, B. M. Stadler, and T. A. Luger: Characterization of a monoclonal antibody directed against the biologically active site of human interleukin-1. J. Exp. Med., 163:463 (1986).
218. Köck, A., T. Schwarz, A. Urbanski, Z. Peng, M. Vetterlein, M. Micksche, J. C. Ansel, H. F. Kung, and T. A. Luger: Expression and release of interleukin-1 by different human melanoma cell lines. J. Natl. Cancer Inst., 81:36 (1989).
219. Koide, S. I., K. Inaba, and R. M. Steinman: Interleukin-1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J. Exp. Med., 165:515 (1987a).
220. Koide, S. and R. M. Steinman: Induction of murine interleukin 1: stimuli and responsive primary cells. Proc. Natl. Acad. Sci. U.S.A., 84:3802 (1987b).
221. Kokia, E., I. Ben-Shlomo, and E. Y. Adashi: The ovarian action of interleukin-1 is receptor mediated: reversal by a naturally occurring interleukin-1 receptor antagonist. Fertil. Steril., 63:176 (1995).
222. Kovacs, E. J., J. J. Oppenheim, and H. A. Young: Induction of c-fos and c-myc expression in T lymphocytes after treatment with recombinant interleukin 1α. J. Immunol., 137:3649 (1986).
223. Kovacs, E. J., J. J. Oppenheim, D. B. Carter, and H. A. Young: Enhanced interleukin-1 production by human monocyte cell lines following treatment with 5-azacytidine. J. Leukocyte Biol., 41:40 (1987).
224. Kovacs, E. J., B. Brock, L. Varesio, and H. A. Young: IL-2 induction of IL-1β mRNA expression in monocytes. Regulation by agents that block second messenger pathways. J. Immunol., 143:3532 (1989).
225. Koyama, N., N. Harada, T. Takahashi, S. Mita, H. Okamura, A. Tominaga, and K. Takatsu: Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation. Immunology, 63:277 (1988).
226. Krakauer, T.: Biochemical characterization of interleukin 1 from a human monocytic cell line. J. Leukocyte Biol., 37:511 (1985).
227. Krakauer, T., J. W. Leduc, and H. Krakauer: Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome. Viral Immunol., 8:75 (1995).
228. Kubera, M., A. Symbirtsev, A. Basta-Kaim, J. Borycz, A. Roman, M. Papp, and M. Claesson: Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol., 48:503 (1996).
229. Kupper, T. S., D. W. Ballard, A. O. Chua, J. S. McGuire, P. M. Flood, M. C. Horowitz, R. Langdon, L. Lightfoot, and U. Gubler: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. J. Exp. Med., 164:2095 (1986).
230. Kurt-Jones, E. A., D. I. Beller, S. Mizel, and E. R. Unanue: Identification of a cell surface associated interleukin 1. Proc. Natl. Acad. Sci. U.S.A., 82:1204 (1985).
231. Kurt-Jones, E. A., W. Fiers, and J. S. Pober: Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J. Immunol., 139:2317 (1987).
232. Lacey, D. L., J. C. Chappel, and S. L. Teitelbaum: Interleukin-1 stimulates proliferation of a nontransformed T lymphocyte line in the absence of a co-mitogen. J. Immunol., 139:2649 (1987).
233. 3. J. Clin. Invest., 91:1731 (1993).
234. Lachman, L. B., C. A. Dinarello, N. D. Llansa, and I. J. Fidler: Natural and recombinant human interleukin 1β is cytotoxic for human melanoma cells. J. Immunol., 136:3098 (1986).
235. Lafage, M., N. Maroc, D. Dubreuil, R. D. Malefijt, M. J. Pébusque, Y. Carcassonne, and P. Mannoni: The human interleukin-1α gene is located on the long arm of chromosome 2 at band q13. Blood, 73:104 (1989).
236. Lai, J. C., E. F. Wawrousek, J. D. Sipe, S. M. Whitecup, and I. Gery: Reduced susceptibility to IL-1 and endotoxin in transgenic mice expressing IL-1 in their lens. Cytokine, 8:288 (1996).
237. Larrick, J. W.: Native interleukin 1 inhibitors. Immunol. Today, 10:61 (1989).
238. Larsen, C. G., C. O. C. Zachariae, J. J. Oppenheim, and K. Matsushima: Production of monocyte chemotactic and activating factor (MCAF) by human fibroblasts in response to interleukin 1 or tumor necrosis factor. Biochem. Biophys. Res. Commun., 160:1403 (1989).
239. Larsson, E. L., N. N. Iscove, and A. Coutinho: Two distinct factors are required for induction of T-cell growth. Nature, 283:664 (1980).
240. Laviano, A., T. Renvyle, M. M. Meguid, Z. J. Yang, C. Cangiano, and F. Rossi Fanelli: Relationship between interleukin-1 and cancer anorexia. Nutrition, 11:680 (1995).
241. Le, J. and J. Vilcek: Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest., 56:234 (1987).
242. Lee, D. H., S. S. Tam, E. Wang, G. R. Taylor, R. K. Plante, and C. Y. Lau: The NF-kappa B inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b/CD18 and CD106. Immunol. Lett., 53:109 (1996).
243. Lee, M., G. M. Segal, and G. C. Bagby: Interleukin-1 induces human bone marrow-derived fibroblasts to produce multilineage hematopoietic growth factors. Exp. Hematol., 15:983 (1987).
244. Lee, S. C., D. W. Dickson, and C. F. Brosnan: Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun., 9:345 (1995).
245. Lee, S. W., A.-P. Tsou, H. Chan, J. Thomas, K. Petrie, E. M. Eugui, and A. C. Allison: Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. U.S.A., 85:1204 (1988).
246. Lewandowicz, J., B. Dabkowska, and D. Nowak: Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis. Arch. Immunol. Ther. Exp., 43:195 (1995).
247. Li, B. Y., D. Mohanraj, M. C. Olson, M. Moradi, L. Twiggs, L. F. Carson, and S. Ramakrishnan: Human ovarian epithelial cancer cells cultured in vitro express both interleukin 1α and 1β genes, Cancer Res., 52:2248 (1992).
248. Liao, Z., R. S. Grimshaw, and D. L. Rosenstreich: Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J. Exp. Med., 159:126 (1984).
249. Liao, Z., Y. Haimovitz, Y. Chen, J. Chan, and D. L. Rosenstreich: Characterization of a human interleukin 1 inhibitor. J. Immunol., 134:3882 (1985).
250. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello: Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol., 124:179 (1986a).
251. Libby, P., J. M. Ordovas, L. K. Birinyi, K. R. Auger, and C. A. Dinarello: Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest., 78:1432 (1986b).
252. Libby, P., S. J. C. Warner, and G. B. Friedman: Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest., 81:487 (1988).
253. Libert, C., W. Van Molle, P. Brouckaert, and W. Fiers: Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality, J. Inflamm., 46:139 (1995-1996).
254. Lin, J.-X. and J. Vilcek: Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J. Biol. Chem., 262:11908 (1987).
255. Lin, T., D. Wang, M. L. Napgal, W. Chang, and J. H. Calkins: Down-regulation of Leydig cell insulin-like growth factor-I gene expression by interleukin-1. Endocrinology, 130:1217 (1992).
256. Lindholm, D., R. Heumann, M. Meyer, and H. Thoenen: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature, 330:658 (1987).
257. Lindholm, D., R. Heumann, B. Hengerer, and H. Thoenen: Interleukin-1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J. Biol. Chem., 263:16348 (1988).
258. Lomedico, P. T., U. Gubler, C. P. Hellmann, M. Dukovich, J. G. Giri, Y.-C. E. Pan, K. Collier, R. Semionov, A. O. Chua, and S. B. Mizel: Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature, 312:458 (1984).
259. Lord, P. C. W., L. M. G. Wilmoth, S. B. Mizel, and C. E. McCall: Expression of interleukin-1 α and β genes by human blood polymorphonuclear leukocytes. J. Clin. Invest., 87:1312 (1991).
260. Lorenzo, J. A., S. L. Sousa, and M. Centrella: Interleukin-1 in combination with transforming growth factor-α produces enhanced bone resorption in vitro. Endocrinology, 123:2194 (1988).
261. Lotem, J. and L. Sachs: Indirect induction of differentiation of normal and leukemic myeloid cells by recombinant interleukin-1. Leukemia Res., 13:13 (1989).
262. Lovett, D., B. Kozan, M. Hadam, K. Resch, and D. Gemsa: Macrophage cytotoxicity: interleukin-1 is a mediator of tumor cytostasis. J. Immunol., 136:340 (1986a).
263. Lovett, D., B. Kozan, M. Hadam, K. Resch, and D. Gemsa: Macrophage cytotoxicity: interleukin 1 is a mediator of tumor cytostasis. J. Immunol., 136:340 (1986b).
264. Lowenthal, J. W., J.-C. Cerottini, and H. R. MacDonald: Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J. Immunol., 137:1226 (1986a).
265. Lowenthal, J. W. and H. R. MacDonald: Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J. Exp. Med., 164:1060 (1986b).
266. + subset of mature T lymphocytes. J. Immunol., 138:1 (1987).
267. Macchia, G., C. T. Baldari, A. Massone, and J. L. Telford: A role for protein kinase C activity in interleukin-1 (IL-1) induction of IL-2 gene expression but not in IL-1 signal transduction. Mol. Cell. Biol., 10:2731 (1990).
268. MacDonald, H. R., P. Wingfield, U. Schmeissner, A. Shaw, G. M. Clore, and A. M. Gronenborn: Point mutations of human interleukin-1 with decreased receptor binding affinity. FEBS Lett., 209:295 (1986).
269. Maes, M., E. Vandoolaeghe, R. Ranjan, E. Bosmans, R. Bergmans, and R. Desnyder: Increased serum interleukin-1- receptor-antagonist concentrations in major depression. J. Affect. Disord., 36:29 (1995).
270. Maier, J. A. M., T. Hia, and T. Maciag: Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem., 265:10805 (1990).
271. Makita, S., S. Nakamura, H. Yoshida, and K. Hiramori: Autocrine growth inhibition of IL-1 beta-treated cultured human aortic smooth muscle cells: possible role of nitric oxide. Heart Vessels, 11:223 (1996).
272. Malinowsky, D., Z. Chai, J. Bristulf, A. Simoncsits, and T. Bartfai: The type 1 interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci. Lett., 201:33 (1995).
273. Mandrup-Poulsen, T., L. D. Wogensen, M. Jensen, P. Svensson, P. Nilsson, T. Emdal, J. Molvig, C. A. Dinarello, and J. Nerup: Circulating interleukin-1 receptor antgaonist concentrations are increased in adult patients with thermal injury. Crit. Care Med., 23:26 (1995).
274. March, C. J., B. Mosley, A. Larsen, D. P. Cerretti, G. Braedt, V. Price, S. Gillis, C. S. Henney, S. R. Kronheim, K. Grabstein, P. J. Conlon, T. P. Hopp, and D. Cosman: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature, 315:641 (1985).
275. Martel-Pelletier, J., R. McCollum, and J. P. Pelletier: The synthesis of EL-1 receptor antagonist (IL-IRA) by synovial fibroblasts is markedly increased by the cytokines TNF-α and IL-1. Biochim. Biophys. Acta, 1175:302 (1993).
276. Martin, M., D. Lovett, and K. Resch: Interleukin 1 induces specific phosphorylation of a 41 kDa plasma membrane protein from the human tumor cell line K 562. Immunobiology, 171:165 (1986).
277. Matsushima, K., T. Akahoshi, M. Yamada, Y. Furutani, and J. J. Oppenheim: Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr Virus-transformed B lymphocytes: identity of the receptor for IL 1-α and IL 1-β. J. Immunol., 136:4496 (1986a).
278. 125I-labeled IL 1β in a human large granular lymphocyte cell line. J. Immunol., 137:3183 (1986b).
279. Matsushima, K., Y. Kobayashi, T. D. Copeland, T. Akahoshi, and J. J. Oppenheim: Phosphorylation of a cytosolic 65-kDa protein induced by interleukin 1 in glucocorticoid pretreated normal human peripheral blood mononuclear leukocytes. J. Immunol., 139:3367 (1987).
280. Maury, C. P. J.: Interleukin 1 and the pathogenesis of inflammatory diseases. Acta Med. Scand., 220:291 (1986).
281. Mauviel, A., N. Temine, D. Charron, G. Loyau, and J.-P. Pujol: Interleukin-1α and β induce interleukin-1β gene expression in human dermal fibroblasts. Biochem. Biophys. Res. Commun., 156:1209 (1988).
282. McDaniel, M. L., J. H. Hughes, B. A. Wolf, R. A. Easom, and J. W. Turk: Descriptive and mechanistic considerations of interleukin 1 and insulin secretion. Diabetes, 37:1311 (1988).
283. McMahan, C. J., J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubin, J. M. Wignall, N. A. Jenkins, C. I. Brannan, N. G. Copeland, K. Huebner, C. M. Croce, L. A. Cannizzarro, D. Benjamin, S. K. Dower, M. K. Spriggs, and J. E. Sims: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J., 10:2821 (1991).
284. McMannis, J. D. and J. M. D. Plate: Xenogeneic antiserum to soluble products from activated lymphoid cells inhibits interleukin 1-mediated functions in the helper pathway of cytolytic-effector-cell differentiation. Proc. Natl. Acad. Sci. U.S.A., 82:1513 (1985).
285. 2 production by human chondrosarcoma cells. J. Immunol., 139:166 (1987).
286. Meyers, C. A., K. O. Johanson, L. M. Miles, P. J. McDevitt, P. L. Simon, R. L. Webb, M.-J. Chen, B. P. Holskin, J. S. Lillquist, and P. R. Young: Purification and characterization of human recombinant interleukin-1β. J. Biol. Chem., 262:11176 (1987).
287. Mine, M., D. Tramontano, W. W. Chin, and S. H. Ingbar: Interleukin-1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. Endocrinology, 120:1212 (1987).
288. Mochizuki, D. Y., J. R. Eisenman, P. J. Conlon, A. D. Larsen, and R. J. Tushinski: Interleukin-1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc. Natl. Acad. Sci. U.S.A., 84:5267 (1987).
289. Montesano, R., L. Orci, and P. Vassalli: Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J. Cell. Physiol., 122:424 (1985).
290. Morinaga, Y., H. Suzuki, F. Takatsuki, Y. Akiyama, T. Taniyama, K. Matsushima, and K. Onozaki: Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J. Immunol., 143:3538 (1989).
291. 1 arrest of a human melanoma cell line by IL-1. Biochem. Biophys. Res. Commun., 173:186 (1990).
292. Morrone, G., G. Ciliberto, S. Oliviero, R. Arcone, L. Dente, J. Content, and R. Cortese: Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem., 263:12554 (1988).
293. Mortensen, R. F., J. Shapiro, B.-F. Lin, S. Douches, and R. Neta: Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins. J. Immunol., 140:2260 (1988).
294. Moser, R., B. Schleiffenbaum, P. Groscurth, and J. Fehr: Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J. Clin. Invest., 83:444 (1989).
295. Mosley, B., S. K. Dower, S. Gillis, and D. Cosman: Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1α and 1β. Proc. Natl. Acad. Sci. U.S.A., 84:4572 (1987a).
296. Mosley, B., D. L. Urdal, K. S. Prickett, A. Larsen, D. Cosman, P. J. Conlon, S. Gillis, and S. K. Dower: The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J. Biol. Chem., 262:2941 (1987b).
297. Muchmore, A. V. and J. M. Decker: Uromodulin. An immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin 1α. J. Biol. Chem., 261:13404 (1986).
298. Muchmore, A. V. and J. M. Decker: Evidence that recombinant IL-1α exhibits lectin-like specificity and binds to homogeneous uromodulin via N-linded oligosaccharides, J. Immunol., 138:2541 (1987a).
299. Muchmore, A. V., S. Shifrin, and J. M. Decker: In vitro evidence that carbohydrate moieties derived from uromodulin, an 85,000 dalton immunosuppressive glycoprotein isolated from human pregnancy urine, are immunosuppressive in the absence of intact protein. J. Immunol., 138:2547 (1987b).
300. Mukaida, N., T. Kasahara, H. Yagisawa, K. Shiori-Nakano, and T. Kawai: Signal requirement for interleukin 1-dependent interleukin 2 production by a human leukemia-derived HSB.2 subclone. J. Immunol., 139:3321 (1987).
301. Murohashi, I., S. Tohda, T. Suzuki, K. Nagata, Y. Yamashita, and N. Nara: Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp. Hematol., 18:133 (1990).
302. Murphy, P. A., P. L. Simon, and W. F. Willoughby: Endogenous pyrogens made by the rabbit peritoneal exudate cells are identical with lymphocyte activating factor made by rabbit alveolar macrophages. J. Immunol., 124:2498 (1980).
303. Nakamura, T., R. Arakaki, and A. Ichihara: Interleukin-1β is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp. Cell Res., 179:488 (1988).
304. Nemeth, K., M. Patthy, I. Fauszt, E. Szell, J. I. Szekely, and S. Bajusz: Effect of peptide aldehydes with Il-1 beta converting enzyme inhibitory properties on IL-1 alpha and IL-1 beta production in vitro. Int. J. Immunopharmacol., 17:985 (1995).
305. Neta, R., M. B. Sztein, J. J. Oppenheim, S. Gillis, and S. D. Douches: The in vivo effects of interleukin-1. I. Bone marrow cells are induced to cycle after administration of interleukin-1. J. Immunol., 139:1861 (1987).
306. Newton, R. C.: Lack of a central role for calcium in the induction and release of human interleukin-1. Biochem. Biophys. Res. Commun., 147:1027 (1987).
307. Newton, R. C. and M. Covington: The activation of human fibroblast prostaglandin E production by interleukin 1. Cell. Immunol., 110:338 (1987).
308. Niiya, K., M. Shinbo, T. Ozawa, Y. Hayakawa, and N. Sakuragawa: Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb. Haemost., 74:1511 (1995).
309. Nishida, T., N. Nishino, M. Takano, K. Kawai, K. Bando, Y. Masui, S. Nakai, and Y. Hirai: cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line. Biochem. Biophys. Res. Commun., 143:345 (1987).
310. Nishida, T., M. Takano, T. Kawakami, N. Nishino, S. Nakai, and Y. Hirai: The transcription of the interleukin 1β gene is induced with PMA and inhibited with dexamethasone in U937 cells. Biochem. Biophys. Res. Commun., 156:269 (1988).
311. Nishida, T., N. Nishino, M. Takano, Y. Sekiguchi, K. Kawai, K. Mizuno, S. Nakai, Y. Masui, and Y. Hirai: Molecular cloning and expression of rat interleukin-1α cDNA. J. Biochem., 105:351 (1989).
312. Noma, T., T. Nakamura, M. Maeda, O. Masafumi, Y. Taniguchi, Y. Tagaya, Y. Yaoita, J. Yodoi, and T. Honjo: Interleukin-1α mRNA in virus-transformed T and B cells. Biochem. Biophys. Res. Commun., 139:353 (1986).
313. Nordsletten, L., A. K. Hogasen, Y. T. Konttinen, S. Santavirta, P. Aspenberg, and A. O. Aasen: Human monocytes stimulation by particles of hydroxyapatiete, silicon carbide and diamond: in vitro studies of new prosthesis coatings. Biomaterials, 17:1521 (1996).
314. Norioka, K., M. Hara, A. Kitani, T. Hirose, W. Hirose, M. Hiragai, K. Suzuki, M. Kawakami, H. Tabata, M. Kawagoe, and H. Nakamura: Inhibitory effect of human recombinant interleukin-1 α and β on growth of human vascular endothelial cells. Biochim. Biophys. Res. Commun., 145:969 (1987).
315. Northoff, H., T. Andus, T.-A. Tran-Thi, J. Bauer, K. Decker, B. Kubanek, and P. C. Heinrich: The inflammation mediators interleukin 1 and hepatocyte-stimulating factor are differentially regulated by human monocytes. Eur. J. Immunol., 17:707 (1987).
316. Novak, T. J., D. Chen, and E. V. Rothenberg: Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol. Cell. Biol., 10:6325 (1990).
317. Numerof, R. P., F. R. Aronson, and J. W. Mier: IL-2 stimultes the production of IL-1α and IL-1β by human peripheral blood mononuclear cells. J. Immunol., 141:4250 (1988).
318. O'Neill, L. A. J., T. A. Bird, A. J. H. Gearing, and J. Saklatvala: Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma cell line (EL4). J. Biol. Chem., 265:3146 (1990).
319. O'Neill, L. A.: Interleukin-1 signal transduction. Int. J. Clin. Lab. Res., 25:169 (1995).
320. Okumura, T., A. Uehara, K. Okamura, Y. Takasugi, and M. Namiki: Inhibition of gastric pepsin secretion by peripherally or centrally injected interleukin-1 in rats. Biochem. Biophys. Res. Commun., 167:956 (1990).
321. Okusawa, S., J. A. Gelfand, T. Ikejima, R. L. Connolly, and C. A. Dinarello: Interleukin-1 induces shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest., 81:1162 (1988).
322. Ollivierre F., U. Gubler, C. A. Towle, C. Laurencin, and B. V. Treadwell: Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochem. Biophys. Res. Commun., 141:904 (1986).
323. Onai, N., Y. Tsunokawa, M. Suda, N. Watanabe, K. Nakamura, Y. Sugimoto, and Y. Kobayashi: Inhibitory effects of bisbenzylisoquinoline alkaloids on induction of proinflammatory cytokines, interleukin-1 and tumor necrosis factor. Planta Med., 61:497 (1995).
324. Onozaki, K., K. Matsushima, E. S. Kleinerman, T. Saito, and J. J. Oppenheim: Role of interleukin-1 in promoting human monocyte-mediated tumor cytotoxicity. J. Immunol., 135:314 (1985).
325. Onozaki, K., T. Tamatani, T. Hashimoto, and K. Matsushima: Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Cancer Res., 47:2397 (1987).
326. Onozaki, K., Y. Akiyama, A. Okano, T. Hirano, T. Kishimoto, T. Hashimoto, K. Yoshizawa, and T. Taniyama: Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines. Cancer Res., 49:3602 (1989).
327. Opara, E. I., A. Laviano, and M. M. Meguid: Correlation between food intake and cerebrospinal fluid interleukin 1 alpha in anorectic tumor-bearing rats. Nutrition, 11:678 (1995).
328. Orr, F. W., M. R. Buchanan, V. A. Tron, D.Guy, D. Lauri, and D. N. Sauder: Chemothactic activity of endothelial cell-derived interleukin 1 for human tumor cells. Cancer Res., 48:6758 (1988).
329. Ostrowski, J., K. E. Meier, T. H. Stanton, L. L. Smith, and K. Bomsztyk: Interferon-γ and interleukin-1α induce transient translocation of protein kinase C activity to membranes in a B lymphoid cell line. Evidence for a protein kinase C-independent pathway in lymphokine-induced cytoplasmic alkalinization. J. Biol. Chem., 263:13786 (1988).
330. Ottaviani, E. and A. Franchini: Immune and neuroendocrine responses in mollusks: the role of cytokines. Acta Biol. Hung., 46:341 (1995).
331. Paciotti, G. F. and L. Tamarkin: Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol. Endocrinol., 2:459 (1988).
332. Paez Pereda, M., C. Ferez Castro, M. Costas, V. E. Nahmod, G. K. Stalla, K. Holsboer, and E. Artz: Glucocorticoids inhibit the autoregulatory induction of interleukin-1 in monocytes after endotoxin stimulation. Neuroimmuno-modulation, 3:227 (1996).
333. Palaszynski, E. W.: Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptor. Biochem. Biophys. Res. Commun., 147:204 (1987).
334. Palkama, T., S. Matikainen, and M. Hurme: Tyrosine kinase activity is involved in the protein kinase C-induced expression of interleukin 1β gene in monocytic cells. FEBS Lett., 319:100 (1993).
335. Panagakos, F. S., J. J. Jandinski, L. Feder, and S. Kumar: Heparin fails to potentiate the effects of IL-1 beta-mediated bone resorption of fetal rat long bones in vitro. Biochimie, 77:915 (1995).
336. Panozzo, M. P., D. Basso, M. DePaoli, P. Carraro, D. Burighel, and M. Plebani: Cytokines may influence tumor growth and spread. Int. J. Clin. Lab. Res., 26:240 (1996).
337. Paris, M. M., I. R. Friedland, S. Ehrett, S. M. Hickey, K. D. Olsen, E. Hansen, E. J. Thonar, and G. H. McCracken: Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. J. Infect. Dis., 171:161 (1995).
338. Parker, K. P., W. R. Benjamin, K. L. Kaffka, and P. L. Kilian: Presence of IL-1 receptors on human and murine neutrophils. Relevance to IL-1-mediated effects in inflammation. J. Immunol., 142:537 (1989).
339. Patterson, D., C. Jones, I. Hart, J. Bleskan, R. Berger, D. Geyer, S. P. Eisenberg, M. F. Smith, and W. P. Arend: The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics, 15:173 (1993).
340. Pellegrini, P., A. M. Berghella, S. Di Loreto, T. Del Beato, F. Di Marco, D. Adorno, and C. U. Casciani: Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1 beta neurotoxic action in physiological repair. Neuroimmunodulation, 3:213 (1996).
341. Pelloux, H., G. Pernod, B. Polack, E. Coursange, J. Ricard, J. M. Verna, and P. Ambroise-Thomas: Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells. Parasitol. Res., 82:598 (1996).
342. Perlmutter, D. H., G. Goldberger, C. A. Dinarello, S. B. Mizel, and H. R. Colten: Regulation of class III major histocompatibility complex gene products by interleukin-1. Science, 232:850 (1986).
343. Peschel, C., I. Green, J. Ohara, and W. E. Paul: Role of B cell stimulatory factor 1/interleukin 4 in clonal proliferation of B cells. J. Immunol., 139:3338 (1987).
344. Pfeilschifter, J., W. Pignat, K. Vosbeck, and F. Märki: Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat mesangial cells, Biochem. Biophys. Res. Commun., 159:385 (1989).
345. Pfeilschifter, J. and H. Schwarzenbach: Interleukin-1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett., 273:185 (1990).
346. Phadke, K.: Fibroblast growth factor enhances the interleukin-1-mediated chondrocytic protease release. Biochem. Biophys. Res. Commun., 142:448 (1987).
347. Pike, B. L. and G. J. V. Nossal: Interleukin-1 can act as a B-cell growth and differentiation factor. Proc. Natl. Acad. Sci. U.S.A., 82:8153 (1985).
348. Pindolia, K. R., C. J. Noth, Y. X. Xu, N. Janakiraman, R. A. Chapman, and S. C. Gautam: IL-4 upregulates IL-1-induced chemokine gene expression in bone marrow stromal cells by enhancing NF-κB activation. Hematopathol. Mol. Hematol., 10:171 (1996).
349. Pirila, L. and J. Heino: Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of alpha 1 beta 1, alpha 6 beta 1, and alpha v beta 5 integrins. J. Rheumatol., 23:1691 (1996).
350. Porat, R., B. D. Clark, S. M. Wolff, and C. A. Dinarello: Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science, 254:430 (1991).
351. Postlethwaite, A. E., R. Raghow, G. P. Stricklin, H. Poppleton, J. M. Seyer, and A. H. Kang: Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin lα and β. J. Cell Biol., 106:311 (1988).
352. Praast, G., R. Hofmeister, K. Grube, W. Hans, T. Kuhlwein, P. H. Krammer, and W. Falk: The internalized interleukin-1 activation complex in fibroblasts localizes to the Golgi apparatus. J. Inflamm., 46:125 (1995-1996).
353. Pujol, J.-P., and G. Loyau: Interleukin-1 and osteoarthritis. Life Sci., 41:1187 (1987).
354. Qwarnstrom, E. E., R.C. Page, S. Gillis, and S. K. Dower: Binding, internalization, and intracellular localization of interleukin-1β in human diploid fibroblasts. J. Biol. Chem., 263:8261 (1988).
355. Qwarnström, E. E., S. A. MacFarlane, R. C. Page, and S. K. Dower: Interleukin 1β induces rapid phosphorylation and redistribution of talin: a possible mechanism for modulation of fibroblast focal adhesion. Proc. Natl. Acad. Sci. U.S.A., 88:1232 (1991).
356. Rabinovitch, A., C. Pukel, and H. Baquerizo: Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology, 122:2393 (1988).
357. Raines, E. W., S. K. Dower, and R. Ross: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science, 243:393 (1989).
358. Ramadori, G., J. D. Sipe, C. A. Dinarello, S. B. Mizel, and H. R. Colten: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J. Exp. Med., 162:930 (1985).
359. Ramaswamy, K., B. Salafsky, S. Potluri, Y. X. He, L. W. Li, and T. Shibuya: Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni. J. Inflamm., 46:13 (1995-1996).
360. Rath, N. C., A. L. Oronsky, and S. S. Kerwar: Synthesis of interleukin-1-like activity by normal rat chondrocytes inculture. Clin. Immunol. Immunopathol., 47:39 (1988).
361. Raz A., A. Wyche, N. Siegel, and P. Needleman: Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem., 263:3022 (1988).
362. Ree, H. J., J. P. Crowley, and C. A. Dinarello: Anti-interleukin-1 reactive cells in Hodgkin's disease. Cancer, 59:1717 (1987).
363. Resch, K., M. Martin, D. H. Lovett, U. Kyas, and D. Gemsa: The receptor for interleukin 1 in plasma membranes of the human leukemia cell K 562: biological and biochemical characterization. Immunobiology, 172:336 (1986).
364. Ristow, H.-J.: A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein. Proc. Natl. Acad. Sci. U.S.A., 84:1940 (1987).
365. Roh, M. S., L. L. Moldawer, L. G. Ekman, C. A. Dinarello, B. R. Bistrian, M. Jeevanandam, and M. F. Brennan: Stimulatory effect of interleukin-1 upon hepatic metabolism. Metabolism, 35:419 (1986).
366. Rosenwasser, L. J., A. C. Webb, B. D. Clark, S. Irie, L. Chang, C.A. Dinarello, L. Gehrke, S. M. Wolff, A. Rich, and P. E. Auron: Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells. Proc. Natl. Acad. Sci. U.S.A., 83:5243 (1986).
367. Roshak, A., E. Mochan, and L. A. Marhall: Suppression of human synovial fibroblast 85 kDa phospholipase A2 by antisense reduces interleukin-1 beta induced prostagladin E2. J. Rheumatol., 23:420 (1996).
368. Rosoff, P. M., N. Savage, and C. A. Dinarello: Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell, 54:73 (1988).
369. Ruggiero, V. and C. Baglioni: Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor. J. Immunol., 138:661 (1987).
370. Sabatini, M., B. Boyce, T. Aufdemorte, L. Bonewald, and G. R. Mundy: Infusions of recombinant human interleukins 1α and 1β cause hypercalcemia in normal mice. Proc. Natl. Acad. Sci. U.S.A., 85:5235 (1988).
371. Sakai, K., T. Hattori, M. Matsuoka, N. Asou, S. Yamamoto, K. Sagawa, and K. Takatsuki: Autocrine stimulation of interleukin 1β in acute myelogenous leukemia cells. J. Exp. Med., 166:1597 (1987).
372. Sandborg, C. I., M. A. Berman, K. L. Imfeld, F. Zaldivar, Jr., M. P. Masada, and J. S. Kenney: Modulation of IL-1α, IL-1β, and 25 K non-IL-1 activity released by human mononuclear cells, J. Leukocyte Biol., 46:117 (1989).
373. Sandborg, C. I., K. L. Imfeld, F. Zaldivar, Jr., and M. A. Berman: HIV type 1 induction of interleukin 1 and 6 production by human thymic cells. AIDS Res. Hum. Retrovir., 10:1221 (1994).
374. Sandier, S., A. Andersson, and C. Hellerström: Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology, 121:1424 (1987).
375. 2 and bone resorption by recombinant human interleukin 1α in fetal mouse bones. Biochem. Biophys. Res. Commun., 138:618 (1986a).
376. 2. Biochem. Biophys. Res. Commun., 141:285 (1986b).
377. Sato, K., Y. Fujii, M. Ono, H. Nomura, and K. Shizume: Production of interleukin 1α-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytes. Cancer Res., 47:6474 (1987a).
378. 2. Biochem. Biophys. Res. Commun., 145:323 (1987b).
379. Sauty, A., M. Pecherstorfer, I. Zimmer-Roth, P. Fioroni, L. Juillerat, M. Markert, H. Ludwig, P. Leuenberger, P. Burckhardt, and D. Thiebaud: Interleukin-6 and tumor necrosis factor alpha levels after biophosphonates treatment in vitro and in patients with malignancy. Bone, 18:133 (1996).
380. Schaafsma, M. R., J. H. F. Falkenburg, N. Duinkerken, J. Van Damme, B. W. Altrock, R. Willemze, and W. E. Fibbe: Interleukin-1 synergizes with granulocyte-macrophage colony-stimulating factor on granulocytic colony formation by intermediate production of granulocyte colony-stimulating factor. Blood, 74:2398 (1989).
381. Schooley, J. C., B. Kullgren, and A. C. Allison: Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br. J. Haematol., 67:11 (1987).
382. Schreiber, S., T. Heinig, U. Panzer, R. Reinking, A. Bouchard, P. D. Sthal, and A. Raedler: Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology, 108:21 (1996).
383. Schwarz, T., A. Urbanska, F. Gschnait, and T. A. Luger: UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity. J. Immunol., 138:1457 (1987).
384. Seckinger, P., K. Williamson, J.-F. Balavoine, B. Mach, G. Mazzei, A. Shaw, and J.-M. Dayer: A urine inhibitor of interleukin 1 activity affects both interleukin 1α and 1β but not tumor necrosis factor a. J. Immunol., 139:1541 (1987).
385. Seelentag, W. K., J.-J. Mermod, R. Montesano, and P. Vassalli: Additive effects of interleukin 1 and tumour necrosis factor-α on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J., 6:2261 (1987).
386. Sellami, S. and R. de Beaurepaire: Hypothalamic and thalamic sites of action of interleukin-1 beta on food intake, body temperature and pain sensitivity in the rat. Brain Res., 694:69 (1995).
387. Shieh, J-H., R. H. F. Peterson, and M. A. S. Moore: Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells. In vivo and in vitro studies. J. Immunol., 147:2984 (1991).
388. Silver, A. R. J., W. K. Masson, A. M. George, J. Adam, and R. Cox: The IL-1α gene and IL-1β gene are closely linked (less than 70-kb) on mouse chromosome 2. Somat. Cell Mol. Genet., 16:549 (1990).
389. Sims, J. E., R. B. Acres, C. E. Grubin, C. J. McMahan, J. M. Wignall, C. J. March, and S. K. Dower: Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. U.S.A., 86:8946 (1989).
390. Singer, I. I., S. Scott, G. L. Hall, G. Limjuco, J. Chin, and J. A. Schmidt: Interleukin 1β is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J. Exp. Med., 167:389 (1988).
391. Singh, J. P., L. D. Adams, and P. D. Bonin: Mode of fibroblast growth enhancement by human interleukin-1. J. Cell. Biol., 106:813 (1988).
392. Sipe, J. D., S. N. Vogel, S. Douches, and R. Neta: Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. Lymphokine Res., 6:93 (1987).
393. Skaper, S. D., L. Facci, and A. Leon: Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem., 64:266 (1995).
394. Skorska, C., J. Milanowski, J. Dutkiewicz, and B. Fafrowicz: Bacterial endotoxins produced by Alcaligenes faecalis and Erwinia herbicola as potential occupational hazards for agricultural workers. Pneumonol. Alergol. Pol., 64:9 (1996).
395. Slack, J., C. J. McMahan, S. Waugh, K. Schooley, M. K. Spriggs, J. E. Sims, and S. K. Dower: Independent binding of interleukin-1α and interleukin-1β to type-I and type-II interleukin-1 receptors. J. Biol. Chem., 268:2513 (1993).
396. Smith, R. J., S. C. Speziale, and B. J. Bowman: Properties of interleukin-1 as a complete secretagogue for human neutrophils. Biochem. Biophys. Res. Commun., 130:1233 (1985).
397. Sobel, D. O., N. Azumi, K. Creswell, D. Holterman, O. C. Blair, J.A. Bellanti, V. Abbassi, and J. C. Hiserodt: The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat. J. Autoimmun., 8:843 (1995).
398. Sorokin, S. P., R. F. Hoyt, Jr., and N. A. McNelly: Factors influencing fetal macrophage development: I. Reactions of the tumor necrosis factor-alpha cascade and their inhibitors. Anat. Rec., 246:481 (1996).
399. 3 for induction and secretion of interleukin-1 by HL-60 cells. Cancer Res., 48:1740 (1988).
400. Stanton, T. H., M. Maynard, and K. Bomsztyk: Effect of interleukin-1 on intracellular concentration of sodium, calcium, and potassium in 70Z/3 cells. J. Biol. Chem., 261:5699 (1986).
401. Stashenko, P., F. E. Dewhirst, W. J. Peros, R. L. Kent, and J. M. Ago: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone marrow resorption. J. Immunol., 138:1464 (1987).
402. Steele, G. L., W. D. Currie, E. H. Leung, B. H. Yuen, and P. C. K. Leung: Rapid stimulation of human chorionic gonadotropin secretion by interleukin-1β from perifused first trimester trophoblast. J. Clin. Endocrinol. Metab., 75:783 (1992).
403. Steinborn, A., H. Gunes, and E. Halberstadt: Signal for term parturition is of trophoblast and therefore of fetal origin. Prostaglandins, 50:237 (1995).
404. Steinkasserer, A., N. K. Spurr, S. Cox, P. Jeggo, and R. B. Sim: The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-lα and IL-1β loci. Genomics, 13:654 (1992).
405. Strulovici, B., S. Daniel-Issakani, E. Oto, J. Jr. Nestor, H. Chan, and A.-P. Tsou: Activation of distinct protein kinase C isozymes by phorbol esters: correlation with induction of interleukin 1β expression. Biochemistry, 28:3569 (1989).
406. Stylianou, E., L. A. J. O'Neill, L. Rawlison, M. R. Edbrooke, P. Woo, and J. Saklatvala: Interleukin-1 induces NF-κB through its type-I but not its type-II receptor in lymphocytes. J. Biol. Chem., 267:15836 (1992).
407. Suda, T., F. Tozawa, T. Ushiyama, T. Sumitomo, M. Yamada, and H. Demura: Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology, 126:1223 (1990).
408. Suffys, P., F. Van Roy, and W. Fiers: Tumor necrosis factor and interleukin 1 activate phospholipase in rat chondrocytes. FEBS Lett., 232:24 (1988).
409. Sujita, K., F. Okuno, Y. Tanaka, Y. Hirano, Y. Inamoto, S. Eto, and M. Arai: Effect of interleukin-1 (IL-1) on the levels of cytochrome P-450 involving IL-1 receptor on the isolated hepatocytes of rat. Biochem. Biophys. Res. Commun., 168:1217 (1990).
410. Suzuki, Y., M. Tanihara, M. Nakagawa, A. Furukawa, C. Masuda, K. Terasawa, Y. Ichikawa, and Y. Mizushima: An interleukin-1 binding region oligopeptide from the human type I IL-1 receptor reduces acute inflammation, delayed hypersensitivity reaction, and lethal endotoxemia in animals. J. Interferon Cytokine Res., 15:1083 (1995).
411. Swendeman, S. and D. A. Thorley-Lawson: The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells. EMBO J., 6:1637 (1987).
412. Takács, L., E. J. Kovacs, M. R. Smith, H. A. Young, and S. K. Durum: Detection of IL-lα and IL-1β gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse. J. Immunol., 141:3081 (1988).
413. Takao, T., K. Hashimoto, and E. B. De Souza: Modulation of interleukin-1 receptors in the brain- endocrine-immune axis by stress and infection. Brain Behav. Immun., 9:276 (1995).
414. Takao, T., I. Nagano, C. Tojo, T. Takemura, S. Makino, K. Hashimoto, and E. B. De Souza: Age-related reciprocal modulation of interleukin-1 beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation, 3:205 (1996).
415. Takei, Y., T. Chiba, S. Nabeshima, M. Naruoka, K. Wada, and K. Onozaki: D-mannose dimr introduced human recombinant interleukin-1 alpha, NEO IL-1 alpha, exhibits altered tissue distribution in mice. J. Interferon Cytokine Res., 16:333 (1996).
416. Takii, T., N. Niki, D. Yang, H. Kimura, A. Ito, H. Hayashi, and K. Onozaki: Type I and type II interferons upregulate functional type I interleukin-1 receptor in a human fibroblast cell line TIG-1. J. Interferon Cytokine Res., 15:1065 (1995).
417. Tamatani, T., H. Urawa, T. Hashimoto, and K. Onozaki: Tumor necrosis factor as an interleukin 1-dependent differentiation inducing factor (D-factor) for mouse myeloid leukemic cells. Biochem. Biophys. Res. Commun., 143:390 (1987).
418. Tamatani, T., H. Tsunoda, H. Iwasaki, M. Kaneko, T. Hashimoto, and K. Onozaki: Existence of both IL-1 α and β in normal human amniotic fluid: unique high molecular weight form of IL-1β. Immunology, 65:337 (1988).
419. Tartakovsky, B., A. Finnegan, K. Muegge, D. T. Brody, E. J. Kovacs, M. R. Smith, J. A. Berzofsky, H. A. Young, and S. K. Durum: IL-1 is an autocrine growth factor for T cell clones. J. Immunol., 141:3863 (1988).
420. Telford, J. L., G. Macchia, A. Massone, V. Carinci, E. Palla, and M. Melli: The murine interleukin 1β gene: structure and evolution. Nucleic Acids Res., 14:9955 (1986).
421. Thomson, B. M., J. Saklatvala, and T. J. Chambers: Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med., 164:104 (1986).
422. Tiku, K., M. L. Tiku, S. Liu, and J. L. Skosey: Normal human neutrophils are a source of a specific interleukin 1 inhibitor. J. Immunol., 136:3686 (1986).
423. Tocci, M. J., N. I. Hutchinson, P. M. Cameron, K. E. Kirk, D. J. Norman, J. Chin, E. A. Rupp, G. A. Limjuco, V. M. Bonilla-Agudo, and J. A. Schmidt: Expression in Escherichia coli of fully active recombinant human IL 1β: comparison with native human IL 1β. J. Immunol., 138:1109 (1987).
424. Tsai, S.-C. and E. V. Gaffney: Inhibition of cell proliferation by interleukin-1 derived from monocytic leukemic cells. Cancer Res., 46:1471 (1986).
425. Tsai, S.-C. J. and E. V.Gaffney: Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon. J. Natl. Cancer Inst., 79:77 (1987).
426. Turnbull, A. V. and C. Rivier: Regulation of the HPA axis by cytokines. Brain Behav. Immun., 9:153 (1995a).
427. Turnbull, A. and C. Rivier: Brain-periphery connections: do they play a role in mediating the effect of centrally injected interleukin-1 beta on gonadal function? Neuroimmunomodulation, 2:224 (1995b).
428. Turunen, J. P., P. Mattila, and R. Kenkonen: cAMP mediates IL-1-induced lymphocyte penetration through endothelial monolayers. J. Immunol., 145:4192 (1990).
429. Uehara, A., P. E. Gottschalk, R. R. Dahl, and A. Arimura: Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology, 121:1580 (1987a).
430. Uehara, A., P. E. Gottschalk, R. R. Dahl, and A. Arimura: Stimulation of ACTH release by human interleukin-1α, but not interleukin-1, in conscious, freely-moving rats. Biochem. Biophys. Res. Commun., 146:1286 (1987b).
431. Urdal, D. L., S. M. Call, J. L. Jackson, and S. K. Dower: Affinity purification and chemical analysis of the interleukin-1 receptor. J. Biol. Chem., 263:2870 (1988).
432. Valentine, M., M. Lotz, C. A. Dinarello, D. A. Carson, and J. H. Vaughan: Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1. Lymphokine Res., 5:173 (1986).
433. Van Damme, J., M. De Ley, G. Opdenakker, A. Billiau, P. De Somer, and J. Van Beeumen: Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature, 314:266 (1985).
434. Van Damme, J., G. Opdenakker, M. de Ley, H. Heremans, and A. Billiau: Pyrogeneic and haematological effects of the interferon-inducing 22K factor (interleukin 1β) from human leukocytes. Clin. Exp. Immunol., 66:303 (1986).
435. van der Meer, M. J., C. G. Sweep, G. J. Pesman, F. J. Tilders, and A. R. Hermus: Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms. Cytokine, 8:910 (1996).
436. van der Meer, M. J., A. R. Hermus, G. J. Pesman, and C. G. Sweep: Effects of cytokines on pituitary beta-endorphin and adrenal corticosterone release in vitro. Cytokine, 8:238 (1996).
437. Van Lent, P. L., F. A. Van De Loo, A. E. Holthuysen, L. A. Van Den Bersselaar, H. Vermeer, and W. B. Van Den Berg: Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J. Rheumatol., 22:2250 (1995).
438. Vanle, L., S. T. Oh, J. A. Anners, C. A. Rinehart, and J. Halme: Interleukin-1 inhibits growth of normal human endometrial stromal cells. Obstet. Gynecol., 80:405 (1992).
439. Vitkovic, L., J. J. Chatham, and A. da Cunha: Distinct expressions of three cytokines by IL-1-stimulated astrocytes in vitro and in AIDS brain. Brain Behav. Immun., 9:378 (1995).
440. Wakasugi, H., L. Rimsky, Y. Mahe, A. M. Kamel, D. Fradelizi, T. Tursz, and J. Bertoglio: Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc. Natl. Acad. Sci. U.S.A., 84:804 (1987).
441. Walter, R., N. Blau, L. Kierat, A. Schaffner, and G. Schoedon: Effects of activating and deactivating cytokines on the functionally linked tetrahydrobiopterin. No pathways in vascular smooth muscle cells. Immunol. Lett., 54:25 (1996).
442. Wang, D. L., M. L. Nagpal, J. H. Calkins, W. W. Chang, M. M. Sigel, and L. Tu: Interleukin-1β induces interleukin-1α messenger ribonucleic acid expression in primary cultures of Leydig cells. Endocrinology, 129:2862 (1991).
443. Wang, M. Q., H. J. Jiang, H. Inoue, M. Myozaki, and U. Yamashita: B cell mitogenic activity of Toxocara canis adult worm. Parasite Immunol., 17:609 (1995).
444. Wano, Y., T. Hattori, M. Matsuoka, K. Takatsuki, A. O. Chua, U. Gubler, and W. C. Greene: Interleukin 1 gene expression in adult T cell leukemia. J. Clin. Invest., 80:911 (1987).
445. Warner, S. J. C., K. R. Auger, and P. Libby: Interleukin-1 induces interleukin-1. II. Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells. J. Immunol., 139:1911 (1987).
446. Warren, R. S., D. B. Donner, H. F. Starnes, Jr., and M. F. Brennan: Modulation of endogenous hormone action by recombinant human necrosis factor. Proc. Natl. Acad. Sci. U.S.A., 84:8619 (1987).
447. Wataha, J. C., S. Ratanasathien, C. T. Hanks, and Z. Sun: In vitro IL-1 beta and TNF-alpha release from THP-1 monocytes in response to metal ions. Dent. Mater., 12:322 (1996).
448. Watanabe, T., A. Morimoto, Y. Sakata, and N. Murakami: ACTH response induced by interleukin-1 is mediated by CRF secretion by hypothalamic PGE. Experientia, 46:481 (1990).
449. Watanobe, H., R. Nasushita, and K. Takebe: A study on the role of circulating prostaglandin E2 in the adrenocor- ticotropin response to intravenous administration of interleukin-1 beta in the rat. Neuroendocrinology, 62:596 (1995).
450. Watanobe, H., J. Anzai, T. Nigawara, S. Habu, and K. Takebe: Effects of gender and gonadectomy on ACTH response to interleukin-1 beta in the rat: comparison with the modulation of ACTH response to immobilization stress. Neuroimmunomodulation, 3:254 (1996).
451. Weaver, C. T. and E. R. Unanue: T-cell induction of membrane IL 1 on macrophages, J. Immunol., 137:3868 (1986).
452. Webb, A. C., K. L. Collins, P. E. Auron, R. L. Eddy, H. Nakai, M. G. Byers, L. L. Haley, W. M. Henry, and T. B. Shows: Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Res., 5:77 (1986).
453. Weitzmann, M. N. and N. Savage: Nuclear internalisation and DNA binding activities of interleukin-1, interleukin-1 receptor and interleukin-1/receptor complexes. Biochem. Biophys. Res. Commun., 187:1166 (1992).
454. Weitzmann, M. N. and N. Savage: Cyclic 3′, 5′-monophosphate, a second messenger in interleukin-1 mediated K562 cytostasis. Biochem. Biophys. Res. Commun., 190:564 (1993).
455. 2+ handling. Acta Endocrinol., 121:698 (1989).
456. Williams, J. M., C. A. Dinarello, L. J. Rosenwasser, V. Kelley, M. Reddish, and T. B. Strom: Phorbol myristate acetate-protein complex mimics bioactivity of human IL-1. Lymphokine Res., 4:275 (1985).
457. Wingfield, P., M. Payton, J. Tavernier, M. Barnes, A. Shaw, K. Rose, M. G. Simona, S. Demczuk, K. Williamson, and J.-M. Dayer: Purification and characterization of human interleukin-1β expressed in recombinant Escherichia coli. Eur. J. Biochem., 160:491 (1986).
458. Winning, T., E. Gemmell, B. Polak, N. W. Savage, G. J. Seymour, and L. J. Walsh: Expression of CD1a in monocytes cultured with supernatants from periodontally diseased gingival epithelial cells. Oral Dis., 2:247 (1996).
459. Winter, S. S., T. Howard, and R. E. Ware: Regulation of expression of the human erythropoietin receptor gene. Blood Cells Mol. Dis., 22:214 (1996).
460. Woloski, B. M. R. N. J. and G. M. Fuller: Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1. Proc. Natl. Acad. Sci. U.S.A., 82:1443 (1985).
461. Wood, T. L., S. L. O'Donnell, and S. W. Levison: Cytokines regulate IGF binding proteins in the CNS. Prog. Growth Factor Res., 6:181 (1995).
462. Yamada, H., T. Kikuchi, O. Nemoto, K. Obata, H. Sato, M. Seiki, and M. Shinmei: Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. J. Rheumatol., 23:1739 (1996).
463. Yamamoto, N., F. Sakai, H. Yamazaki, Y. Kawai, K. Nakahara, and M. Okuhara: Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. J. Rheumatol., 23:1778 (1996).
464. Yang, Y-C., S. Tsai, G. G. Wong, and S. C. Clark: Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J. Cell. Physiol., 134:292 (1988).
465. Yoshimura, T., C. Kurita, E. Usami, T. Nakao, S. Watanabe, J. Kabayashi, F. Yamazaki, and H. Nagai: Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemotherapy, 42:459 (1996).
466. Yu, H. S. and J. Ferner: Interleukin-1α induces a sustained increase in cytosolic free calcium in cultured rabbit osteoclasts. Biochem. Biophys. Res. Commun., 191:343 (1993).
467. Zandman-Goddard, G., J. George, M. Bland, Y. Levy, P. Yanai, T. Halperin, Y. Shoenfeld, and V. Barak: The effect of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus. Immunol. Lett., 53:77 (1996).
468. Zawalich, W. S. and V. A. Diaz: Interleukin-1 inhibits insulin secretion from isolated perifused rat islets. Diabetes, 35:1119 (1986).
469. Zawalich, W. S. and K. C. Zawalich: Interleukin-1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis. Am. J. Physiol., 256:E19 (1989a).
470. Zawalich, W. S., K. C. Zawalich, and H. Rasmussen: Interleukin-1α exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. Endocrinology, 124:2350 (1989b).
471. Zhang, Y., J.-X. Lin, and J. Vilcek: Enhacement of cAMP levels and protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc. Natl. Acad. Sci. U.S.A., 85:6802 (1988).
472. 2. J. Clin. Invest., 77:1857 (1986).
473. Zucali, B. R., H.E. Broxmeyer, C. A. Dinarello, M. A. Gross, and R. S. Weiner: Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium. Blood, 69:33 (1987a).
474. Zucali, J. R., G. J. Elfenbein, K. C. Earth, and C. A. Dinarello: Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation. J. Clin. Invest., 80:772 (1987b).